講演情報
[WS12-13-P]DNAM-1 exacerbates intestinal inflammation by activating ILC3 via the Akt/mTORC1/HIF-1α signaling pathway
○Natsuki Ide1,2, Kazuki Sato1, Kenshiro Matsuda1,3, Kazuko Shibuya1,3, Akira Shibuya1,3,4 (1.Department of Immunology, Institute of Medicine, University of Tsukuba, 2.Ph.D. Program in Human Biology, 3.R&D Center for Innovative Drug Discovery, University of Tsukuba, 4.TNAX Biopharma Inc.)
キーワード:
ILC
閲覧にはパスワードが必要です
ログイン
または